Mayo Clinic Launches Focused Nine-Gene Panel for Hereditary Pancreatitis
The new test expands from four genes to nine while maintaining clinical focus, addressing diagnostic challenges with PRSS1 testing accuracy.
Read MorePosted by CLP Edit Staff | Sep 30, 2025 | Gastrointestinal Infections |
The new test expands from four genes to nine while maintaining clinical focus, addressing diagnostic challenges with PRSS1 testing accuracy.
Read MorePosted by CLP Edit Staff | Sep 26, 2025 | Molecular Diagnostic Analyzers |
The companies plan to create a fully automated PCR testing system for infectious disease diagnosis and treatment monitoring.
Read MorePosted by CLP Edit Staff | Sep 26, 2025 | Sequencing Systems |
New research demonstrates the ultra-sensitive SNV detection capabilities of ppmSeq technology, with error rates reaching as low as 8 x 10-8 for minimal residual disease applications.
Read MorePosted by Alyx Arnett | Sep 25, 2025 | Lung Cancer |
On World Lung Day, Reveal Dx board member Mat Brevard discusses why current diagnostic tools fall short—and how new approaches could improve accuracy and outcomes.
Read MorePosted by CLP Edit Staff | Sep 24, 2025 | Molecular Diagnostic Analyzers |
The collaboration combines Lunit’s AI expertise with Agilent’s diagnostic leadership to improve biomarker testing and enhance precision medicine capabilities.
Read More